Nike Inc (NKE) 121.86 $NKE Winning With China; Fed

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nike Inc (NKE) 121.86 $NKE

Winning With China; Fed Unfriends Wall Street: Jim Cramer's Best Blogs
at The Street - Fri Nov 13, 8:00PM CST
Catch up on Jim Cramer's ideas from this past week, when he wrote about how China's growth helps some U.S. companies, and why the Fed doesn't care about your portfolio.
SBUX: 59.74 (-1.33), NKE: 121.86 (-4.12), CMI: 98.67 (+0.84), UTX: 96.48 (-2.74), FCX: 8.68 (-0.09), M: 39.10 (-1.72), AKS: 2.55 (+0.03), CAT: 69.63 (+0.97), AAPL: 112.34 (-3.38), X: 9.75 (+0.07)

Rough Week For IBD 50 Stocks, But Some Bright Spots
at Investor's Business Daily - Fri Nov 13, 5:40PM CST
Friday the 13th put an exclamation point on a week that shareholders in many leading stocks would just as soon forget. After five straight weeks of gains, the IBD 50 index declined 3.9% compared to the S&P 500, which was down 3.6%. It didn't help...
NTES: 148.11 (-5.23), CBM: 48.97 (+0.65), NKE: 121.86 (-4.12), MANH: 71.39 (-1.96), DY: 81.82 (-1.10), PAYC: 41.04 (-3.31)

Under Armour outruns Nike
at Investor's Business Daily - Fri Nov 13, 5:34PM CST
The trendy sportswear maker scored a 155% jump in athletic footwear sales for the week ended Nov. 7, as it continues to build from a very low base. Athletic shoe sales rose 0.2% for larger rival Nike, 17.4% for Skechers USA, and 10.6% for Adidas. But...
UA: 87.43 (-4.93), NKE: 121.86 (-4.12), SKX: 25.40 (-1.20)

Nike Leads 4 Fitness Stocks Making Notable Moves
at Investor's Business Daily - Fri Nov 13, 3:34PM CST
The broader market is selling off again today, with many stocks testing technical levels. Let's take a look at how four fitness-related stocks are faring: Nike (NKE), Under Armour (UA), Fitbit (FIT) and Planet Fitness (PLNT). Follow Alissa Williams...
FIT: 27.86 (-3.82), UA: 87.43 (-4.93), NKE: 121.86 (-4.12), PLNT: 16.07 (+1.04)

Shoe Sales: Under Armour Outruns Nike By A Mile
at Investor's Business Daily - Fri Nov 13, 3:24PM CST
Under Armour (UA) continued to flex its muscles with shoppers last week by scoring athletic footwear sales gains that far outpaced its much larger rival Nike (NKE), but the trendy sportswear brand didn't reap the rewards among investors as shares...
UA: 87.43 (-4.93), NKE: 121.86 (-4.12), SKX: 25.40 (-1.20), DB: 25.51 (-0.50)

JD.com Gains 5% on Robust Singles' Day Sales Numbers
Zacks Equity Research - Zacks Investment Research - Fri Nov 13, 12:25PM CST
China's top online direct sales company JD.com's (JD) total order volume increased a whopping 130% year over year.
NKE: 121.86 (-4.12), JD: 26.75 (-2.03), AAPL: 112.34 (-3.38), BABA: 75.85 (-2.91)

Credit Suisse's 11 Consumer Stocks Most Exposed to the 'Healthy Living' Trend
at The Street - Fri Nov 13, 11:07AM CST
Which stocks will continue to benefit from the global shift by consumers to live more healthy lifestyles? Here are 11 to consider.
WFM: 29.55 (-0.36), UA: 87.43 (-4.93), NKE: 121.86 (-4.12), DKS: 41.17 (-1.61), GIL: 28.53 (-0.31), VFC: 62.05 (-2.56), HRL: 66.17 (-0.26), FL: 58.04 (-3.31), MTN: 114.91 (+0.73), PLNT: 16.07 (+1.04), LULU: 45.05 (-3.11)

Nike, Inc.'s CEO Is Crushing It -- And He's Stepping It Up
Daniel Sparks, The Motley Fool - Motley Fool - Fri Nov 13, 11:02AM CST
In Fortune 's Businessperson of the Year list, the magazine looks for a CEO whose company is "firing on all cylinders" and whose leadership is "unique and distinct," comments Fortune assistant managing editor Adam Lashinsky. Nike CEO Mark...
UA: 87.43 (-4.93), NKE: 121.86 (-4.12), LULU: 45.05 (-3.11)

Reports of Retail's Death Are Greatly Exaggerated
at The Street - Fri Nov 13, 9:00AM CST
Consumers are still spending, they're just doing it differently.
ZUMZ: 14.66 (-0.80), NKE: 121.86 (-4.12), M: 39.10 (-1.72), BBY: 32.04 (-1.95), KORS: 39.00 (-2.64), SHLD: 22.17 (-1.35), FINL: 16.34 (-0.93), SBUX: 59.74 (-1.33), WHR: 151.07 (-4.43), UA: 87.43 (-4.93), TJX: 64.21 (-4.04), ANF: 19.90 (-1.14), AEO: 14.69 (-0.91), TGT: 71.89 (-3.04), JCP: 7.44 (-1.35), JWN: 53.96 (-9.51), FL: 58.04 (-3.31), AAPL: 112.34 (-3.38)

Nordstrom Adds to Retail Pain With Disappointing Earnings Results
at The Street - Fri Nov 13, 4:00AM CST
The CNBC 'Fast Money' traders examine stocks after a rough day of trading Thursday, before turning their attention to the struggling retail sector.
VRX: 75.41 (+1.64), HD: 120.00 (-3.81), SHAK: 40.85 (-1.62), NKE: 121.86 (-4.12), M: 39.10 (-1.72), UA: 87.43 (-4.93), SPY: 202.54 (-2.30), TJX: 64.21 (-4.04), ERIC: 9.24 (-0.01), SUNE: 4.93 (+0.39), CMG: 592.89 (-21.79), JWN: 53.96 (-9.51), MCD: 109.97 (-2.14), CSCO: 26.21 (-1.62)

Mixed Feelings on Rate Hike; Time to Buy Retail?
at The Street - Thu Nov 12, 2:03PM CST
The CNBC 'Fast Money' traders talk to Mario Gabelli and Steve Kernkraut about the retail environment and whether there are any deals to be had.
KSS: 42.85 (-2.94), AMZN: 642.35 (-23.25), NKE: 121.86 (-4.12), GPC: 85.83 (-1.43), ORLY: 259.83 (-7.07), M: 39.10 (-1.72), LULU: 45.05 (-3.11), UA: 87.43 (-4.93), SPY: 202.54 (-2.30), LB: 90.59 (-2.43), AZO: 755.25 (-19.96), TJX: 64.21 (-4.04), JCP: 7.44 (-1.35), JWN: 53.96 (-9.51), AAPL: 112.34 (-3.38), ROST: 44.81 (-3.30)

If the Consumer Spending Is Strong, Why Are Retailers Struggling?
at The Street - Thu Nov 12, 4:00AM CST
The CNBC 'Fast Money' traders hear from former J.C. Penney CEO Allen Questrom about retail, before debating the best ways to play.
UA: 87.43 (-4.93), AMZN: 642.35 (-23.25), V: 78.11 (-0.20), SPY: 202.54 (-2.30), SPG: 186.34 (-4.74), NKE: 121.86 (-4.12), JCP: 7.44 (-1.35), JWN: 53.96 (-9.51), M: 39.10 (-1.72), MA: 96.86 (-1.42), BABA: 75.85 (-2.91)

Jim Cramer's 'Mad Money' Recap: The End of Shopping as We Know It
at The Street - Wed Nov 11, 7:20PM CST
Consumers should be flush with cash. Find out where those extra dollars are being spent and you'll find profits.
F: 13.92 (-0.12), ZBRA: 67.71 (-3.33), NKE: 121.86 (-4.12), RTN: 117.25 (-0.96), UTX: 96.48 (-2.74), DAL: 48.99 (-0.99), XOM: 78.10 (-1.31), M: 39.10 (-1.72), INTC: 32.11 (-0.29), LUV: 45.89 (-0.80), SBUX: 59.74 (-1.33), T: 32.31 (-0.38), W: 36.52 (-2.39), SAVE: 33.77 (-0.53), ETP: 39.62 (+1.37), SONC: 26.98 (-0.55), CMI: 98.67 (+0.84), COST: 153.67 (-2.33), SYF: 30.52 (-0.27), CAT: 69.63 (+0.97), MSFT: 52.84 (-0.48), TWTR: 25.18 (-0.95), AAPL: 112.34 (-3.38), AMZN: 642.35 (-23.25), HD: 120.00 (-3.81), LSTR: 61.08 (-0.37), DIS: 114.84 (-1.37), BMY: 64.15 (+0.43), DRH: 11.15 (-0.25), CVS: 91.81 (-1.31), BRK.B: 131.96 (-0.82), BABA: 75.85 (-2.91)

Watch for NIKE to Potentially Rebound After Falling 1.98% Yesterday
Comtex SmarTrend(R) - Wed Nov 11, 4:32PM CST
NIKE (NYSE:NKE) traded in a range yesterday that spanned from a low of $127.28 to a high of $130.59. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $129.27 on volume of 4.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NKE: 121.86 (-4.12)

Look for Shares of NIKE to Potentially Rebound after Yesterday's 1.98% Sell Off
Comtex SmarTrend(R) - Wed Nov 11, 4:32PM CST
NIKE (NYSE:NKE) traded in a range yesterday that spanned from a low of $127.28 to a high of $130.59. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $129.27 on volume of 4.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NKE: 121.86 (-4.12)

Another Day of Consolidation in the Books
at The Street - Wed Nov 11, 3:12PM CST
The bulls couldn't gain any traction as markets finished the sessions near their lows.
SBUX: 59.74 (-1.33), AMZN: 642.35 (-23.25), NKE: 121.86 (-4.12), FB: 103.95 (-4.07), GOOGL: 740.07 (-16.46), MSFT: 52.84 (-0.48), NVDA: 29.80 (-0.60)

Jim Cramer Says Amazon Rules This Holiday Season, Bah Humbug Macy's
at The Street - Wed Nov 11, 12:20PM CST
Amazon is expected to go higher this holiday season, because the company's business model is so good.
AGN: 299.63 (-0.41), AMZN: 642.35 (-23.25), GE: 30.28 (+0.12), ESRX: 82.99 (-1.47), SHAK: 40.85 (-1.62), NKE: 121.86 (-4.12), HZNP: 17.99 (+0.38), JCP: 7.44 (-1.35), MCD: 109.97 (-2.14), M: 39.10 (-1.72), JWN: 53.96 (-9.51), SYF: 30.52 (-0.27), TIF: 74.47 (-2.35), AAPL: 112.34 (-3.38)

Hedge Funds Love These 5 Big Stocks -- Should You Too?
at The Street - Wed Nov 11, 7:31AM CST
These stocks were some of hedge funds' favorite buys in the most recently reported quarter.
HD: 120.00 (-3.81), EBAY: 28.19 (-0.37), NKE: 121.86 (-4.12), FB: 103.95 (-4.07), M: 39.10 (-1.72), DB: 25.51 (-0.50), PYPL: 34.53 (-1.04), MO: 56.28 (-0.48)

Is This a Bull or a Bear Market?
at The Street - Wed Nov 11, 6:44AM CST
The market is once again near all-time highs, but there's a lot of congestion in the 2110 to 2135 zone for the S&P 500.
SBUX: 59.74 (-1.33), AMZN: 642.35 (-23.25), NKE: 121.86 (-4.12), GOOGL: 740.07 (-16.46), MSFT: 52.84 (-0.48), NVDA: 29.80 (-0.60)

The Champs in China's New Growth Story
at The Street - Wed Nov 11, 5:58AM CST
The U.S. is still winning the trade war -- and these companies are leading the charge.
SBUX: 59.74 (-1.33), CMI: 98.67 (+0.84), NKE: 121.86 (-4.12), UTX: 96.48 (-2.74), AKS: 2.55 (+0.03), CAT: 69.63 (+0.97), AAPL: 112.34 (-3.38), X: 9.75 (+0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 238

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 12

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 315

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 286

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 110

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 183

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Anytime Fitness Launches First Club in Dubai, UAE, Expanding Reach

Updated Category News Views 508

Anytime Fitness Sets Foot in Dubai with Grand Opening The new club in the Arjan district signifies a vital expansion of fitness services to the United Arab Emirates; members benefit from personalized wellness plans, state-of-the-art Technogym equipment, and SmartCoaching services available through the AF App. Purpose Brands LLC has announced the grand opening of its very...

Continue Reading
Crescent Biopharma's Strategic Partnership and Market Moves

Updated Category News Views 196

Crescent Biopharma's Recent Stock Activity Crescent Biopharma, Inc. (NASDAQ: CBIO) has been experiencing a notable fluctuation in its stock value lately. Shares initially showed a positive trend, indicating investor optimism following their recent announcement, but later reversed course and began to dip slightly. This change in trading comes as the company unveiled a...

Continue Reading
Investors Alert: Legal Developments for Snap Inc. Shareholders

Updated Category News Views 167

Important Update for Snap Inc. Shareholders If you have invested in Snap Inc. (NYSE: SNAP) and purchased shares in 2021 or earlier, there are significant legal developments that you should be aware of. A recent lawsuit is reportedly pending, and the Shareholders Foundation has urged impacted investors to take action. Details of the Lawsuit Against Snap Inc. The lawsuit...

Continue Reading
Understanding the Influence of Trump's Fiscal Policies on Debt

Updated Category News Views 493

Understanding the Influence of Trump's Fiscal Policies on Debt When it comes to government debt, being large isn't necessarily an advantage. Recent fiscal policies introduced by the Trump administration, including tariffs and the initiatives of the Department of Government Efficiency, aim to address the growing fiscal deficit. However, the overall effect may result in...

Continue Reading
Analyzing Sea's Short Interest Trends and Market Implications

Updated Category News Views 128

Understanding Sea's Short Interest Dynamics Sea's short percent of float has notably increased by 5.22% since the latest report. The company currently has 21.99 million shares sold short, which accounts for 7.46% of its total shares available for trading. Based on recent trading volumes, it would take an average of 5.24 days for traders to cover their short positions....

Continue Reading